Venus Medtech (Hangzhou) Inc

02500

Company Profile

  • Business description

    Venus Medtech (Hangzhou) Inc is engaged in the medical devices that integrate R&D, clinical development, manufacturing, and commercialization. The company has developed a product portfolio covering the interventional devices for valvular heart diseases, including transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), and other procedural accessories, allowing it to provide overall solutions for physicians and patients. Geographically, the company operates in mainland China, Israel, Hong Kong, the USA, and the Netherlands. The majority of the revenue is derived from Mainland China.

  • Contact

    No. 88, Jiangling Road
    Room 311, 3rd Floor, Block 2
    Binjiang District
    Hangzhou310051
    CHN

    T: +86 57187772180

    https://www.venusmedtech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    560

Stocks News & Analysis

stocks

Bumper performance from ASX listed tech share

User growth hurt by technical issues.
stocks

Our view after CBA shares plunge

Steady profit, but rising risks and rich valuation give pause.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

Amid robust demand for semis, watch for any impact of in-house built chips and whether the supply chain is on track.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,884.7018.300.21%
CAC 408,082.270.000.00%
DAX 4024,456.26319.451.32%
Dow JONES (US)50,081.90388.700.78%
FTSE 10010,372.9347.580.46%
HKSE26,389.040.600.00%
NASDAQ26,670.54268.201.02%
Nikkei 22562,654.05618.06-0.98%
NZX 50 Index13,025.0737.99-0.29%
S&P 5007,507.3963.140.85%
S&P/ASX 2008,640.7026.000.30%
SSE Composite Index4,177.9264.65-1.52%

Market Movers